Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

M C Stühlinger1, P S Tsao, J H Her

  • 1Section of Vascular Medicine, Stanford University, Stanford, California, USA.

Circulation
|November 21, 2001
PubMed

Insights

High homocysteine levels increase asymmetric dimethylarginine (ADMA) by inhibiting its degrading enzyme, DDAH. This finding explains how homocysteine impairs blood vessel function and nitric oxide synthesis.

Area of Science:

  • Biochemistry
  • Cardiovascular Science
  • Molecular Biology

Background:

  • Hyperhomocysteinemia is linked to cardiovascular disease and impaired endothelium-dependent vasodilation.
  • Elevated asymmetric dimethylarginine (ADMA) is a potential mechanism for cardiovascular risk factors affecting vascular function.
  • ADMA is an endogenous inhibitor of nitric oxide synthase (NOS).

Purpose of the Study:

  • To investigate whether homocysteine can increase ADMA levels.
  • To elucidate the mechanism by which homocysteine might affect ADMA.

Main Methods:

  • Exposure of endothelial and nonvascular cells to DL-homocysteine or L-methionine.
  • Measurement of ADMA concentration in cell culture medium.
  • Assessment of dimethylarginine dimethylaminohydrolase (DDAH) activity.
  • Evaluation of nitric oxide synthesis in endothelial cells and aortic segments.
  • In vitro studies using recombinant human DDAH.

Main Results:

  • Homocysteine increased ADMA levels in a dose- and time-dependent manner.
  • This increase in ADMA was associated with reduced DDAH activity.
  • Homocysteine-induced ADMA accumulation led to decreased nitric oxide synthesis.
  • Pyrrolidine dithiocarbamate partially reversed these effects.
  • Homocysteine directly inhibited recombinant human DDAH activity.

Conclusions:

  • Homocysteine post-translationally inhibits DDAH enzyme activity.
  • This inhibition causes ADMA accumulation, which in turn inhibits nitric oxide synthesis.
  • The study provides a molecular mechanism for homocysteine's adverse effects on endothelium-mediated vasodilation.
Abstract

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
4.9K
Preparation of Amines: Reduction of Oximes and Nitro Compounds01:29

Preparation of Amines: Reduction of Oximes and Nitro Compounds

Oximes can be reduced to primary amines using catalytic hydrogenation, hydride reduction, or sodium metal reduction. The reduction of aliphatic and aromatic nitro compounds to primary amines takes place by either catalytic hydrogenation or by using active metals like Fe, Zn, and Sn in the presence of an acid.
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
3.7K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.3K
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
100
Sulfur Assimilation01:20

Sulfur Assimilation

Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to...
562
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
1.7K